Sort
64,565 grants matching “drug discovery”
Carbohydrate-based Therapy for Lung Disease
$2,565,954John V Fahy · University Of California, San Francisco · P01 · FY2018 · HL
Improving Prediction of Drug Action
$2,564,195Dan M Roden · Vanderbilt University Medical Center · P50 · FY2016 · GM
Genetics and Bioinformatics Core Laboratory
$2,563,727Daniel Weinberger · National Institute Of Mental Health · ZIC · FY2009 · MH
Agents of Bioterrorism: Pathogenesis and host defense
$2,562,708Jorge L. Benach · State University New York Stony Brook · P01 · FY2008 · AI
Vascular remodeling in patients with rare genetic disorders
$2,562,680Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Rutgers University CounterACT Center of Excellence
$2,562,572Jeffrey D Laskin · Rutgers Biomedical And Health Sciences · U54 · FY2024 · AR
University of Texas PDX Development and Trial Center
$2,561,686Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Center for Translational Cancer Nanomedicine
$2,558,928Vladimir P Torchilin · Northeastern University · U54 · FY2011 · CA
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
$2,557,740Mark Lee · Fisher Bioservices, Inc. · N02 · FY2022 · CA
The Pediatric Brain Tumor Consortium (PBTC)
$2,553,687James M Boyett · St. Jude Children'S Research Hospital · U01 · FY2006 · CA
UCLA Center for Biological Radioprotectors
$2,551,193William H. McBride · University Of California Los Angeles · U19 · FY2009 · AI
Rutgers University CounterACT Center of Excellence
$2,550,317Jeffrey D Laskin · Rutgers Biomedical And Health Sciences · U54 · FY2022 · AR
Rutgers University CounterACT Center of Excellence
$2,550,317Jeffrey D Laskin · Rutgers Biomedical And Health Sciences · U54 · FY2023 · AR
Metabolic determinants of Mtb virulence, vulnerability and variation
$2,547,329David Branch Moody · Brigham And Women'S Hospital · U19 · FY2021 · AI
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,545,763David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Glucocorticoid Hormone Action
$2,545,319John A. Cidlowski · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Carbohydrate-based Therapy for Lung Disease
$2,543,475John V Fahy · University Of California, San Francisco · P01 · FY2020 · HL
Cancer Center Support Grant
$2,543,187Steven Terry Rosen · Beckman Research Institute/City Of Hope · P30 · FY2018 · CA
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
$2,542,664James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2018 · AI
Mayo Clinic Multiple Myeloma SPORE
$2,538,499Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2018 · CA
NCI-Frederick Support and Technical Services
$2,538,497Norman Sharpless · Office Of The Director, Nci · ZIC · FY2018 · CA
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,537,842Robert A Britton · Baylor College Of Medicine · U19 · FY2023 · AI
Agents of Bioterrorism: Pathogenesis and host defense
$2,537,421Jorge L. Benach · State University New York Stony Brook · P01 · FY2007 · AI
The Vanderbilt Molecular Target Discovery and Development Center
$2,536,958Lawrence J Marnett · Vanderbilt University · RC2 · FY2010 · CA
Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function
$2,536,038John T Lis · Cornell University · RM1 · FY2023 · GM